Epithelial to Mesenchymal Transition Marker in 2D and 3D Colon Cancer Cell Cultures in the Presence of Laminin 332 and 411

被引:4
作者
Maltseva, D. V. [1 ,2 ]
Makarova, J. A. [2 ,3 ]
Khristichenko, A. Yu. [1 ]
Tsypina, I. M. [1 ,4 ]
Tonevitsky, E. A. [1 ]
Rodin, S. A. [1 ,5 ]
机构
[1] SRC Bioclin, Moscow 115088, Russia
[2] Minist Healthcare Russian Federat, Natl Med Res Radiol Ctr, Branch Fed State Budgetary Inst, Hertsen Moscow Oncol Res Ctr, Obninsk 249036, Russia
[3] Russian Acad Sci, Inst Mol Biol, Moscow 119991, Russia
[4] Natl Res Univ, Higher Sch Econ, Moscow 101000, Russia
[5] Karolinska Inst, Dept Med Biochem & Biophys, SE-17177 Stockholm, Sweden
基金
俄罗斯基础研究基金会;
关键词
laminin-332; laminin-5; laminin-411; laminin-8; basal membrane; colon cancer; HT-29; HCT-116; RKO; epithelial-mesenchymal transition; apical-basal cell polarity; in vitro model; 2D culture; 3D culture;
D O I
10.1134/S0026893319020110
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The loss of apical-basal cell polarity is a necessary stage of the epithelial-mesenchymal transition (EMT). Polarized epithelial cells interact with the basement membrane (BM) and, in particular, with laminins, the major components of BM. Here, we examined the effect of the transition of colon cancer cells from 2D polarized state to non-polarized 3D state on the expression of EMT associated genes, as well as the role of laminins 332 and 411 (LM-332 and LM-411) in this process. The three studied cell lines, HT-29, HCT-116 and RKO, were found to have different sensitivity to cultivation conditions (2D to 3D changes) and to addition of laminins. One of the possible reasons for this may be a difference in the initial 2D state of the cells. In particular, it was shown that the cell lines were at different EMT stages. HT-29 exhibited more epithelial expression profile, RKO was more mesenchymal, and HCT-116 was in an intermediate state. The most laminin-sensitive cell line was HCT-116. The magnitude and the specificity of cell response to LM-332 and LM-411 depended on the expression pattern of laminins' receptors. EMT gene expression profile was not substantially changed neither during the transition from 2D to 3D state, nor the presence of laminins' isoforms. However, we detected changes in expression of SNAI1 and ZEB1 genes encoding transcription factors that control the EMT process. Notably, in all three studied cell lines, the expression of SNAI1 was enhanced in response to laminin treatment.
引用
收藏
页码:291 / 298
页数:8
相关论文
共 50 条
  • [41] 3D-cultured adipose tissue-derived stem cells inhibit liver cancer cell migration and invasion through suppressing epithelial-mesenchymal transition
    Xie, Haihua
    Liao, Naishun
    Lan, Fenghua
    Cai, Zhixiong
    Liu, Xiaolong
    Liu, Jingfeng
    INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE, 2018, 41 (03) : 1385 - 1396
  • [42] Propofol inhibits colon cancer cell stemness and epithelial-mesenchymal transition by regulating SIRT1, Wnt/β-catenin and PI3K/AKT/mTOR signaling pathways
    Wang, Runjia
    Li, Shuai
    Hou, Qi
    Zhang, Bo
    Chu, Huaqing
    Hou, Yu
    Ni, Cheng
    Sun, Li
    Ran, Yuliang
    Zheng, Hui
    DISCOVER ONCOLOGY, 2023, 14 (01)
  • [43] Propofol inhibits colon cancer cell stemness and epithelial-mesenchymal transition by regulating SIRT1, Wnt/β-catenin and PI3K/AKT/mTOR signaling pathways
    Runjia Wang
    Shuai Li
    Qi Hou
    Bo Zhang
    Huaqing Chu
    Yu Hou
    Cheng Ni
    Li Sun
    Yuliang Ran
    Hui Zheng
    Discover Oncology, 14
  • [44] Cell Type-Specific TGF-β Mediated EMT in 3D and 2D Models and Its Reversal by TGF-β Receptor Kinase Inhibitor in Ovarian Cancer Cell Lines
    Al Ameri, Wafa
    Ahmed, Ikhlak
    Al-Dasim, Fatima M.
    Mohamoud, Yasmin Ali
    Al-Azwani, Iman K.
    Malek, Joel A.
    Karedath, Thasni
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2019, 20 (14)
  • [45] Differential effectiveness of tyrosine kinase inhibitors in 2D/3D culture according to cell differentiation, p53 status and mitochondrial respiration in liver cancer cells
    Rodriguez-Hernandez, Maria A.
    Chapresto-Garzon, Raquel
    Cadenas, Miryam
    Navarro-Villaran, Elena
    Negrete, Maria
    Gomez-Bravo, Miguel A.
    Victor, Victor M.
    Padillo, Francisco J.
    Muntane, Jordi
    CELL DEATH & DISEASE, 2020, 11 (05)
  • [46] MEF2D Transduces Microenvironment Stimuli to ZEB1 to Promote Epithelial-Mesenchymal Transition and Metastasis in Colorectal Cancer
    Su, Li
    Luo, Yongli
    Yang, Zhi
    Yang, Jing
    Yao, Chao
    Cheng, Feifei
    Shan, Juanjuan
    Chen, Jun
    Li, Fangfang
    Liu, Limei
    Liu, Chungang
    Xu, Yanmin
    Jiang, Lupin
    Guo, Deyu
    Prieto, Jesus
    Avila, Matias A.
    Shen, Junjie
    Qian, Cheng
    CANCER RESEARCH, 2016, 76 (17) : 5054 - 5067
  • [47] Analysis of Polymer/siRNA Nanoparticle Efficacy and Biocompatibility in 3D Air-Liquid Interface Culture Compared to 2D Cell Culture
    Noske, Sandra
    Krueger, Martin
    Ewe, Alexander
    Aigner, Achim
    PHARMACEUTICS, 2025, 17 (03)
  • [48] STAT3 activation in HER2-overexpressing breast cancer promotes epithelial-mesenchymal transition and cancer stem cell traits
    Chung, Seyung S.
    Giehl, Nolan
    Wu, Yanyuan
    Vadgama, Jaydutt V.
    INTERNATIONAL JOURNAL OF ONCOLOGY, 2014, 44 (02) : 403 - 411
  • [49] Platelet-derived growth factor-D overexpression contributes to epithelial-mesenchymal transition of PC3 prostate cancer cells
    Kong, Dejuan
    Wang, Zhiwei
    Sarkar, Sarah H.
    Li, Yiwei
    Banerjee, Sanjeev
    Saliganan, Allen
    Kim, Hyeong-Reh Choi
    Cher, Michael L.
    Sarkar, Fazlul H.
    STEM CELLS, 2008, 26 (06) : 1425 - 1435
  • [50] Transcriptomic analysis reveals that combinations of vitamins A, D2, and D3 have synergistic effects in HCT-116 colon cancer cells by altering the expression of genes involved in multiple canonical pathways including apoptosis, regulation of the epithelial mesenchymal transition and immunity
    Kanabar, Pinal N.
    Los, Nina S.
    Lawal, Temitope O.
    Patel, Shitalben
    Maienschein-Cline, Mark
    Arbieva, Zarema
    Mahady, Gail B.
    FUNCTIONAL FOODS IN HEALTH AND DISEASE, 2021, 11 (04): : 154 - 178